Cliff Asness AQR Capital Management
Cliff Asness is a co-founder of AQR Capital Management, a leading quantitative investment firm spanning equities, alternatives, and factor strategies. He is known for academic-informed research on value, momentum, and other systematic premia, as well as candid market commentary. Asness’s work bridges academic finance and large-scale institutional portfolio management.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
EOG Resources
EOG
|
+$143M |
| 2 |
WNR
Western Refining Inc
WNR
|
+$142M |
| 3 |
DTV
DIRECTV COM STK (DE)
DTV
|
+$137M |
| 4 |
BHI
Baker Hughes
BHI
|
+$135M |
| 5 |
POM
PEPCO HOLDINGS, INC.
POM
|
+$113M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
BEAM
BEAM INC COM STK (DE)
BEAM
|
+$215M |
| 2 |
LSI
LSI CORPORATION
LSI
|
+$185M |
| 3 |
Omnicom Group
OMC
|
+$165M |
| 4 |
BRE
BRE PROPERTIES INC CL A
BRE
|
+$95M |
| 5 |
JOSB
JOS A BANK CLOTHIERS INC
JOSB
|
+$83M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 14.95% |
| 2 | Technology | 13.55% |
| 3 | Financials | 10.47% |
| 4 | Energy | 10.33% |
| 5 | Industrials | 9.15% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
401
American Express
AXP
$227B
| $18.9M | 0.05% |
198,797
-28,600
| -13% | -$2.58M |
|
402
Equifax
EFX
$22.6B
| $18.8M | 0.05% |
259,161
-60,500
| -19% | -$4.25M |
|
|
OMCC
403
DELISTED
Old Market Capital Corp
OMCC
| $18.8M | 0.05% |
1,306,032
+244,150
| +23% | +$3.67M |
|
404
Starwood Property Trust
STWD
$6.06B
| $18.8M | 0.05% |
788,904
+200
| +0% | +$4.76K |
|
405
Huntington Bancshares
HBAN
$34.4B
| $18.7M | 0.05% |
1,964,629
+547,978
| +39% | +$5.15M |
|
406
PENN Entertainment
PENN
$2.5B
| $18.6M | 0.05% |
1,532,951
+84,904
| +6% | +$1M |
|
407
Brinker International
EAT
$10.6B
| $18.6M | 0.05% |
382,078
-31,600
| -8% | -$1.58M |
|
|
THOR
408
DELISTED
THORATEC CORPORATION
THOR
| $18.6M | 0.05% |
532,600
+79,000
| +17% | +$2.63M |
|
|
UNT
409
DELISTED
UNIT Corporation
UNT
| $18.5M | 0.05% |
268,661
+104,800
| +64% | +$6.83M |
|
410
Cemex
CX
$16B
| $18.5M | 0.05% |
1,569,122
+6,185
| +0.4% | +$70.3K |
|
411
International Paper
IP
$22B
| $18.4M | 0.05% |
391,229
-10,066
| -3% | -$441K |
|
412
Genuine Parts
GPC
$18.5B
| $18.4M | 0.05% |
209,068
-4,000
| -2% | -$344K |
|
|
CHL
413
DELISTED
China Mobile Limited
CHL
| $18.3M | 0.05% |
377,232
+11,500
| +3% | +$552K |
|
|
MXIM
414
DELISTED
Maxim Integrated Products
MXIM
| $18.1M | 0.05% |
534,800
+104,900
| +24% | +$3.49M |
|
415
Sysco
SYY
$40.2B
| $18M | 0.05% |
481,111
+123,500
| +35% | +$4.53M |
|
416
Newell Brands
NWL
$2.59B
| $17.9M | 0.05% |
577,673
+66,300
| +13% | +$1.98M |
|
417
Rithm Capital
RITM
$5.69B
| $17.9M | 0.05% |
1,419,533
+800
| +0.1% | +$10.1K |
|
|
SGY
418
DELISTED
Stone Energy
SGY
| $17.8M | 0.05% |
6,699
+4,031
| +151% | +$10.2M |
|
419
Gerdau
GGB
$8.5B
| $17.8M | 0.05% |
3,807,594
+2,910,978
| +325% | +$14.3M |
|
420
Freeport-McMoran
FCX
$110B
| $17.8M | 0.05% |
486,986
+445,400
| +1,071% | +$15.2M |
|
|
PETM
421
DELISTED
PETSMART INC
PETM
| $17.7M | 0.05% |
295,374
-186,800
| -39% | -$11.8M |
|
422
Lindblad Expeditions
LIND
$2.04B
| $17.5M | 0.05% |
1,781,900
-100
| -0% | -$992 |
|
|
NEE.PRO
423
DELISTED
NEXTERA ENERGY INC UNITS EXPIRING 09/01/2015 (FL)
NEE.PRO
| $17.4M | 0.05% |
266,725
+97,050
| +57% | +$6.05M |
|
424
JetBlue
JBLU
$1.85B
| $17.2M | 0.05% |
7,344,410
-177,000
| -2% | -$1.64M |
|
|
CAMB
425
DELISTED
CAMBRIDGE CAP ACQUISITION CORP (DE)
CAMB
| $17.2M | 0.05% |
1,760,000
| – | – |
|
Similar funds
Cliff Asness's Q2 2014 Portfolio in Review
As of Q2 2014, Cliff Asness held 2,714 positions worth $37.1B, up 12% from $33.1B the previous quarter. Its ten largest holdings account for 8.6% of the portfolio.
Cliff Asness's Q2 2014 filing shows 178 new, 1,030 increased, 953 reduced and 205 closed positions. Its largest new stake was AstraZeneca: 1,186,418 shares worth $88.2M. The largest sale was BEAM INC COM STK (DE), an estimated $215M.
By sector, the portfolio is most concentrated in Healthcare at 15% of assets, up from 15% a quarter earlier, followed by Technology and Financials.
- Cliff Asness's largest Q2 2014 buy was AstraZeneca: 1,186,418 shares worth $88.2M.
- Cliff Asness added most to EOG Resources in Q2 2014, an estimated $143M increase.
- Cliff Asness's biggest Q2 2014 reduction was Omnicom Group, cutting an estimated $165M.
- Cliff Asness fully exited BEAM INC COM STK (DE) in Q2 2014, selling an estimated $215M.
- Cliff Asness's ten largest holdings make up 8.6% of its $37.1B portfolio in Q2 2014.
- Cliff Asness opened 178 new positions and closed 205 in Q2 2014.
- Cliff Asness's portfolio value rose 12% quarter-over-quarter to $37.1B.
Based on AQR Capital Management's 13F filing for Q2 2014, filed 14 Aug 2014.